The investment seeks capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category SmallBlend
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 38.32 | N/A | N/A |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| SPBW | 28.78 | -0.06 | -0.22% |
| AllianzIM Buffer20 Allocation ETF | |||
| SMIG | 33.12 | -0.09 | -0.27% |
| Bahl & Gaynor Sm/Md Cp Inc Gr ETF | |||
| IJAN | 37.98 | -0.17 | -0.45% |
| Innovator Itnl Dvp Pwr Buff ETF™ Jan | |||
| MBCE | 38.69 | -1.03 | -2.59% |
| Monarch Blue Chips Elite Index ETF | |||
A.I.dvisor indicates that over the last year, SLPAX has been closely correlated with FTHFX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SLPAX jumps, then FTHFX could also see price increases.
| Ticker / NAME | Correlation To SLPAX | 1D Price Change % | ||
|---|---|---|---|---|
| SLPAX | 100% | N/A | ||
| FTHFX - SLPAX | 92% Closely correlated | N/A | ||
| DFSTX - SLPAX | 86% Closely correlated | -0.54% | ||
| FSSNX - SLPAX | 19% Poorly correlated | N/A | ||
| VSMAX - SLPAX | 13% Poorly correlated | N/A | ||
| NAESX - SLPAX | 13% Poorly correlated | N/A | ||
More | ||||